Read + Share
Nierengarten MB. First person profile: Julie Brahmer, MD: Dr Brahmer's research paved the way for
the first immunotherapy agent to receive US Food and Drug Administration approval
for the treatment of lung cancer. Cancer 2025;131:e35686.
PMID: 39829070
|
 |
|
